source
- Dr Mauro on the Significance of Alternative TKI Formulations in CMLMichael Mauro, MD, details the FDA approval of the small-molecule formulation of dasatinib and other alternate TKI formulations in chronic myeloid leukemia.onclive · 2mo ago↗ source
- Key takeaways from WHO briefing on hantavirus cruise ship outbreakHere are key takeaways from a WHO briefing on the hantavirus outbreak aboard a cruise ship.STAT · 2mo ago↗ source
- Women With Bladder Cancer Face Diagnostic Delays as Symptoms Mimic UTIs, Experts WarnTimothy N. Clinton, MD, and Stephanie A. Berg, DO, discuss gender differences in bladder cancer during Bladder Cancer Awareness Month.onclive · 2mo ago↗ source